Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Veracyte Buys Convergent Genomics

Veracyte Buys Convergent Genomics

MT newswireMT newswire2026/09/14 20:22
04:22 PM EDT, 09/14/2026 (MT Newswires) -- Veracyte (VCYT) said late Monday it has acquired Convergent Genomics for $150 million in upfront cash and up to additional $30 million tied to milestones over UroAmp reimbursement efforts. The company said the acquisition expands its urology diagnostics portfolio with a urinary tumor DNA testing platform. Veracyte said it contemplated Convergent's operating expenses in 2026 adjusted EBITDA outlook and is not updating its guidance.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!